Home›Research›Compare›ACE-031 vs Sermorelin
Peptide ComparisonACE-031 vs Sermorelin
ACE-031
ACVR2B-Fc
Half-life: ~14 days
4 providers listed
Sermorelin
GHRH 1-29
Half-life: 10–20 minutes
449 providers listed
ACE-031 and Sermorelin target different goals — ACE-031 for myostatin/activin inhibition, Sermorelin for pulsatile GH release via direct GHRH receptor agonism at the pituitary. They're compared here for reference, not as direct substitutes.
ACE-031
Half-life
~14 days
Sermorelin
Half-life
10–20 minutes
ACE-031 and Sermorelin target different goals — ACE-031 for Muscle & Myostatin, Sermorelin for GH / IGF Axis. They're compared here for reference; there isn't a single “better” choice between them.
ACE-031
Sermorelin
Sermorelin
The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients…
The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostat…
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodyb…
About ACE-031
Soluble decoy receptor for ActRIIB; sequesters myostatin, activin, and GDF-11 to remove multiple brakes on muscle and bone growth simultaneously
About Sermorelin
Sermorelin is a synthetic analogue of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on pituitary somatotrophs, stimulating pulsatile GH secretion in a physiological pattern that preserves the natural hypothalamic-pituitary feedback axis — contrasting with direct GH administration. Downstream IGF-1 elevation mediates many of its body composition, tissue-repair, and sleep quality effects.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
ACE-031
No established clinical contraindications
Sermorelin
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Sermorelin clinical protocols measure IGF-1 as the primary marker of GH axis response. Fasting glucose and insulin are standard baseline assessments given GH's effect on insulin sensitivity.
Sermorelin
Ipamorelin
Research suggests Sermorelin and Ipamorelin may produce complementary growth hormone release effects when combined. Sermorelin acts as a GHRH analogue via pituitary receptors, while Ipamorelin acts via ghrelin receptors — dual-pathway stimulation studied in GH optimization research.
ACE-031
Sermorelin
Where to source these peptides
ACE-031
4 listed
Browse directory →
Providers offeringSermorelin
449 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
Related Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). ACE-031 vs Sermorelin — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/ace-031/sermorelin